Oat β-
glucan consumption is linked to reduced risk factors associated with diabetes and
obesity by lowering glycemic response and serum level of
low-density lipoproteins. The purpose of this study was to identify the mechanism of action of oat β-
glucan at the interface between the gut wall and the lumen responsible for attenuating
glucose levels. We proposed that viscous oat β-
glucan acts as a physical barrier to
glucose uptake in normally absorptive gut epithelial cells IEC-6 by affecting the expression of intestinal
glucose transporters. Concentration and time-dependent changes in
glucose uptake were established by using a nonmetabolizable
glucose analog 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-
2-deoxy-d-glucose. The effectiveness of nutrient transport in IEC-6 cells was shown by significant differences in
glucose uptake and corresponding transporter expression. The expressions of
glucose transporters sodium-
glucose-linked
transport protein 1 (SGLT1) and
glucose transporter 2 (GLUT2) increased with time (0-60 minutes) and
glucose levels (5-25 mmol/L). The suppression of
glucose uptake and SGLT1 and GLUT2 expression by increasing concentrations (4-8 mg/mL) of oat β-
glucan demonstrated a direct effect of the physical properties of oat β-
glucan on
glucose transport. These results affirmed oat β-
glucan as a dietary agent for minimizing postprandial
glucose and showed that modulating the activity of the key intestinal
glucose transporters with oat β-
glucan could be an effective way of lowering
blood glucose levels in patients with diabetes.